Search results
Results From The WOW.Com Content Network
Chinese virus A term for COVID-19 used by former United States president Donald Trump to emphasize that the pandemic started in China. Comirnaty. Main article: Comirnaty. The commercial name for the FDA approved COVID-19 vaccine from Pfizer, released August 21, 2021. It also has several other names or designators used on the actual vials.
The US CDC's COVID-19 laboratory test kit. COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2, the virus that cases COVID-19 and is responsible for the COVID-19 pandemic. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection.
While COVID-19 refers to the disease and SARS-CoV-2 refers to the virus which causes it, referring to the "COVID-19 virus" has been accepted. [9] [25] [29] Reference to SARS-CoV-2 as "the coronavirus" has become somewhat accepted despite such use implying that there is only one coronavirus species. Similarly, use of "COVID" for the disease (if ...
The development of COVID-19 tests was a major public health priority during the early months of the COVID-19 pandemic. In January 2020, scientists from China published the first genetic sequences of SARS-CoV-2 via virological.org , [ 3 ] a "hub for prepublication data designed to assist with public health activities and research". [ 4 ]
New COVID-19 variants continue to pop up. Experts explain how many COVID variants there are, important subvariants, and the evolution of SARS-CoV-2 virus. ... In the case of COVID-19, the virus ...
To complete the preclinical stage of drug development – then be tested for safety and efficacy in an adequate number of people infected with COVID-19 (hundreds to thousands in different countries) – is a process likely to require 1–2 years for COVID-19 therapies, according to several reports in early 2020.
In May 2020, a rapid antigen test from Quidel Corporation received EUA for detecting SARS-CoV-2. [8] Test results were said to be available at point of care within 15 minutes. [9] Sensitivity is 85%. [1] Also in May 2020, a CRISPR genetic test was approved for emergency use that claimed 100% selectivity and 97.5% sensitivity. [10] That month ...
Researchers at Boston’s Dana-Farber Cancer Institute are working on a drug that takes one of the virus’s most dangerous traits — its talent for mutation — and turns it back on itself.